Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Glavni autor: | Tamanna, Mst. Taskia |
---|---|
Daljnji autori: | Sharmin, Dr. Sabrina |
Format: | Disertacija |
Jezik: | English |
Izdano: |
Brac University
2023
|
Teme: | |
Online pristup: | http://hdl.handle.net/10361/18146 |
Similar Items
-
Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
od: Hassan, Md. Muhtaz
Izdano: (2020) -
Role of protein’s and future treatment options for Alzheimer’s Disease
od: Islam, Md. Irfath
Izdano: (2023) -
Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
od: Alim, Abdul
Izdano: (2023) -
Marine compounds in the treatment of Alzheimer’s disease
od: Parveen, Sanjana
Izdano: (2022) -
Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
od: Tabassum, Nadira
Izdano: (2024)